Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Oy Casamarin Ab
OY
Active
Y-tunnus 2176131-9
Kronbergsgatan 1C-134, 00160
Helsingfors
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2008 · 18 years old
— employees
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Oy Casamarin Ab
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
32
58
57
27
3
Staff expenses
−11
−14
−17
−1
−0
EBITDA
14
28
30
15
−4
Depreciation & amort.
—
—
−0
−0
−0
EBIT
14
28
30
15
−4
Net financials
−0
0
−0
−0
0
Profit before tax
14
28
30
14
−4
Tax
−0
5
6
3
−0
Net profit
14
23
24
12
−4
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
25
45
43
31
17
Equity
21
34
28
16
0
Long-term debt
—
—
0
0
0
Short-term debt
5
11
6
4
1
Total debt
5
11
6
4
1
Financial ratios
5-year trend
EBITDA margin
-140.9%
This company
15.8%
Market median
-992% vs market
2021
2025
Equity ratio
2.6%
This company
38.2%
Market median
-93% vs market
2021
2025
Return on equity
-815.3%
This company
18.4%
Market median
-4531% vs market
2021
2025
Net profit margin
-139.2%
This company
8.1%
Market median
-1819% vs market
2021
2025
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
2021
2025
Debt / equity
37.43×
This company
0.62×
Market median
-5937% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Oy Casamarin Ab
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
